Skip to main content

Leukemia, Acute Myeloid

Jan Cerny, MD, PhD Reviewed 06/2020
 


BASICS

DESCRIPTION

  • Acute myeloid leukemia (AML) is characterized by proliferation and accumulation of abnormal immature myeloid progenitors (blasts) with reduced capacity to differentiate into more mat...

DIAGNOSIS

HISTORY

Fatigue (anemia or tumor burden); bleeding (low platelets or DIC); difficulty clearing infections (neutropenia or immune dysregulation) 

PHYSICAL EXAM

  • Mostly nonspecific and related to ...

TREATMENT

  • Chemotherapy is the backbone of AML therapy; it consists of induction and consolidation phase ± maintenance (APL).

  • Bone marrow transplantation (BMT) for high-risk AML

  • Only modest improvements ...

ONGOING CARE

FOLLOW-UP RECOMMENDATIONS

Ambulatory, as tolerated; no intense or contact sports; no aspirin due to risk of bleeding 

Patient Monitoring

  • Repeat bone marrow studies to document remission and ...

REFERENCES

1
Döhner H, Estey EH, Amadori S, et al; for European LeukemiaNet. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf ...

ADDITIONAL READING

O’Donnell MR, Appelbaum FR, Coutre SE, et al. Acute myeloid leukemia. J Natl Compr Canc Netw.  2008;6(10):962–993. 

SEE ALSO

Disseminated Intravascular Coagulation; Leukemia, Acu...

CODES

ICD10

  • C92.00 Acute myeloblastic leukemia, not having achieved remission

  • C92.01 Acute myeloblastic leukemia, in remission

  • C92.02 Acute myeloblastic leukemia, in relapse

ICD9

  • 205.00 Acute myeloid leuke...

CLINICAL PEARLS

  • AML is a proliferation and accumulation of abnormal immature myeloid progenitors (blasts) with reduced capacity to differentiate into more mature cellular elements. This leads to bone ...

Subscribe to Access Full Content

Sign Up for a 10-Day Free Trial

Sign up for a 10-day FREE Trial now and receive full access to all content.

 
×